Funding Concerns in the DBT Biocare Programme: Structural Deficits in R&D Policy Execution
The DBT Biocare programme is a significant policy effort aimed at addressing systemic gender inequities in India's research ecosystem. Conceptually, the programme intersects "equity-driven science funding" with "institutional execution deficits." Despite its intent to empower unemployed female scientists through extramural funding, the delay in disbursing sanctioned funds exposes structural weaknesses in India's R&D governance. This issue reflects the broader challenges of underinvestment in science and technology infrastructure and ineffective fund management mechanisms.
UPSC Relevance Snapshot
- GS-III: Science and Technology – Research and development policies, gender equity in scientific careers.
- GS-IV: Ethics in governance – Accountability in fund disbursement under public schemes.
- Essay Paper: Themes on gender equity, science for development, and public sector inefficiencies.
Conceptual Analysis: Programme Intent vs Governance Deficits
Central to the DBT Biocare programme’s delay lies the conflict between "targeted funding for social inclusion" and "institutional execution inertia." The programme aims to bridge gender gaps in India’s scientific workforce through structured R&D funding but is constrained by inefficiencies in fund sanctioning and delivery protocols.
- Equity-driven Science Funding: The programme specifically targets unemployed female Ph.D. researchers, providing them ₹60 lakh over three years, including a ₹75,000 monthly salary component.
- Institutional Execution Deficits: Despite 75 researchers being selected in 2025, delayed fund sanctioning has stalled their projects. Administrative bottlenecks weaken the impact of well-intentioned schemes.
- Broader Governance Context: Relates to India’s structural underperformance in GERD (Gross Expenditure on Research and Development), which consistently remains below global benchmarks.
Evidence and Data: India's R&D Underinvestment vs Global Standards
India’s R&D funding framework is symptomatic of broader financial and structural limitations. Low GERD levels, coupled with reduced private-sector participation, exacerbate programme inefficiencies like those seen in Biocare.
| Country | GERD as % of GDP | Private Sector Contribution |
|---|---|---|
| India | 0.6–0.7% | ~36% |
| China | 2.4% | ~70% |
| South Korea | 4.5% | ~77% |
| United States | 2.8% | ~70% |
Limitations and Unresolved Issues
The DBT Biocare programme’s delays in funding implementation reflect structural and systemic shortcomings that require urgent governance improvements. However, several open questions persist regarding the scheme's design and effectiveness.
- Administrative Bottlenecks: Lack of synchronization between MoST, DBT, and disbursement agencies results in execution delays.
- Scalability Concerns: Increasing the number of beneficiaries annually while maintaining fund adequacy raises questions of sustainability.
- Absence of Private-Sector Partnerships: Limited engagement from private research bodies affects scope for collaborative innovation.
- Brain Drain Risk: Talented scientists may seek opportunities abroad due to systemic delays and inadequate support in domestic career development platforms.
Structured Assessment of Funding Concerns
- Policy Design: Clear objectives for gender equity but underpinned by fiscal and operational fragility.
- Governance Capacity: Weak administrative machinery delays fund utilization and restrict programme impact.
- Behavioural/Structural Factors: Limited transparency in fund disbursement mechanisms and enduring gender disparities in Indian scientific careers.
Exam Integration
- Which of the following accurately describes India's GERD (Gross Expenditure on Research and Development)?
- A) India’s GERD exceeds 2% of GDP.
- B) India’s GERD is below 1% of GDP, with private-sector contribution around 36%.
- C) India’s GERD matches that of South Korea.
- D) India does not calculate GERD regularly.
- DBT Biocare Programme primarily focuses on:
- A) Agricultural Biotechnology Research
- B) Career Development for Unemployed Female Scientists
- C) Collaborative Research between Public and Private Sectors
- D) High-Yielding Seed Development
Frequently Asked Questions
What are the primary objectives of the DBT Biocare programme?
The DBT Biocare programme aims to address systemic gender inequities in India's research ecosystem by providing targeted funding to unemployed female Ph.D. researchers. It offers ₹60 lakh over three years, including a monthly salary component, to empower women scientists and bridge the gender gap in scientific careers.
What challenges are associated with the implementation of the DBT Biocare programme?
The programme faces significant challenges due to administrative bottlenecks and delays in fund disbursement, which impede the timely execution of research projects. Additionally, the lack of synchronization between involved agencies and limited private-sector participation further complicates effective fund management and hampers overall impact.
How does India's Gross Expenditure on Research and Development (GERD) compare to global standards?
India's GERD, ranging from 0.6% to 0.7% of GDP, is considerably lower than other countries like China (2.4%), South Korea (4.5%), and the United States (2.8%). This underperformance in R&D investment highlights structural weaknesses in India's science and technology policies, characterized by insufficient funding and private-sector engagement.
About LearnPro Editorial Standards
LearnPro editorial content is researched and reviewed by subject matter experts with backgrounds in civil services preparation. Our articles draw from official government sources, NCERT textbooks, standard reference materials, and reputed publications including The Hindu, Indian Express, and PIB.
Content is regularly updated to reflect the latest syllabus changes, exam patterns, and current developments. For corrections or feedback, contact us at admin@learnpro.in.